期刊文献+

冠心康对ApoE^(-/-)动脉粥样硬化小鼠PPARγ-LXRα-ABCA1信号通路的影响 被引量:23

Effects of Chinese herbal medicine Guanxinkang on expression of PPARγ- LXRα-ABCA1 pathway in ApoE-knockout mice with atherosclerosis
下载PDF
导出
摘要 目的:观察中药复方冠心康对载脂蛋白E(apolipoprotein E,ApoE)基因敲除(ApoE-/-)动脉粥样硬化(atherosclerosis,AS)小鼠三磷酸腺苷结合盒转运体A1(ATP-binding cassette transporterA1,ABCA1)通路的影响。方法:70只ApoE-/-小鼠用高脂饲料喂养建立小鼠AS模型。14只C57BL/6J小鼠为正常对照组,给予普通饲料。70只ApoE-/-小鼠造模成功后随机分为5组,即模型组、高剂量冠心康组(生药浓度为3.456g/mL)、中剂量冠心康组(1.728g/mL)、低剂量冠心康组(0.864g/mL)和西药辛伐他汀组[3mg/(kg·d)]。每只小鼠灌胃0.5mL,每天1次。连续灌胃8周后取材,分离肝脏及主动脉。运用蛋白质印迹法检测各组小鼠过氧化物酶体增殖物激活型受体γ(peroxisome proliferator-activated receptorγ,PPARγ)、肝X受体α(liver X receptor α,LXRα)和ABCA1蛋白的表达,实时荧光定量聚合酶链反应法检测各组小鼠主动脉、肝脏PPARγ、LXRα和ABCA1mRNA的表达。结果:与C57BL/6J小鼠比较,ApoE-/-小鼠的主动脉、肝脏的PPARγ、LXRα、ABCA1mRNA的表达明显增高;与模型组小鼠比较,高、中剂量冠心康与辛伐他汀在不同程度上下调了主动脉、肝脏的PPARγ、LXRα、ABCA1mRNA的表达(P<0.05),而以高剂量冠心康的作用最为突出。低剂量组无明显改变(P>0.05)。与C57BL/6J小鼠比较,ApoE-/-小鼠的主动脉、肝脏的PPARγ、LXRα、ABCA1蛋白的表达明显增高;与模型组小鼠比较,各用药组主动脉、肝脏的PPARγ、LXRα、ABCA1蛋白的表达量下降(P<0.05),而以冠心康高剂量组作用最为突出。结论:PPARγ-LXRα-ABCA1通路在ApoE-/-小鼠脂质代谢紊乱、炎症反应方面扮演重要角色。复方冠心康能改善ApoE-/-小鼠动脉粥样硬化过程中的脂质代谢紊乱,抑制炎症反应的进展,可能与调控ApoE-/-小鼠的主动脉、肝脏PPARγ、LXRα、ABCA1 mRNA及蛋白的表达有关。 OBJECTIVE:To observe the effects of Guanxinkang(GXK)decoction,a compound traditional Chinese herbal medicine,on expressions of peroxisome proliferator-activated receptorγ(PPARγ),liver X receptorα (LXRα)and ATP-binding cassette transporter A1(ABCA1)in apolipoprotein E(ApoE)-knockout mice with atherosclerosis. METHODS:Fourteen 6-week-old C57BL/6 J mice were used as normal control group.Seventy 6-week-old ApoE-knockout mice receiving a high-cholesterol diet to induce atherosclerosis were randomly divided into untreated group,simvastatin group and low-dose(concentration of crude drugs at 0.864 g/mL),mediumdose(crude drugs at 1.728 g/mL)and high-dose(crude drugs at 3.456 g/mL)GXK groups.After treated with the drugs for eight weeks continuously,the livers and aortas of mice were separated.The expressions of PPARγ,LXRαand ABCA1 were measured by real-time quantitative polymerase chain reaction and Western blotting respectively. RESULTS:Compared with the normal control group,mRNAs and proteins of PPARγ,LXRαand ABCA1 over-expressed in the untreated group(P0.05).After the treatment,GXK decoction and simvastatin decreased the expressions of PPARγ,LXRαand ABCA1(P0.05).High-dose GXK decoction had more marked effects than low-and medium-dose GXK and simvastatin. CONCLUSION:The PPARγ-LXRα-ABCA1 pathway is involved in lipid regulation and inflammation activities. Over-expression of the genes has complicated effects on atherosclerosis in ApoE-knockout mice with high- cholesterol diet.GXK decoction has anti-inflammatory and anti-matrix metalloproteinase activities by regulating PPARγ,LXRαand ABCA1interactions in the ApoE-knockout mice.
出处 《中西医结合学报》 CAS 2012年第7期814-820,共7页 Journal of Chinese Integrative Medicine
基金 国家自然科学基金资助项目(No.30873340)
关键词 中草药 动脉粥样硬化 载脂蛋白E 三磷酸腺苷结合盒转运体A1 过氧化物酶体增殖物激活型受体Γ 肝X受体Α 小鼠 drugs Chinese herbal atherosclerosis apolipoprotein E ATP-binding cassette transporter A1 peroxisome proliferator-activated receptor γ liver X receptor α mice
  • 相关文献

参考文献12

  • 1Soumian S, Albrecht C, Davies AH, Gibbs RG. ABCA1 and atherosclerosis. Vasc Med. 2005; 10 (2): 109-119.
  • 2毛美娇,胡俊萍,陈富荣,章怡祎,刘萍.冠心康对载脂蛋白E基因敲除动脉粥样硬化小鼠血脂及炎性标志物的影响[J].中西医结合学报,2011,9(3):306-312. 被引量:24
  • 3Hanriot D, Bello G, Ropars A, Seguin-Devaux C, Poitevin G, Grosjean S, Latger-Cannard V, Devaux Y, Zannad F, Regnault V, Lacolley P, Metres PM, Hess K, Longrois D. C-reactive protein induces pro- and anti-inflammatory effects, including activation of the liver X receptor alpha, on human monocytes. Thromb Haemost. 2008; 99(3): 558-569.
  • 4Filep JG. Perplexity of monocyte responses to C-reactive protein (CRP). Thromb Haemost. 2008; 99(3): 461- 462.
  • 5Lawn RM, Wade DP, Couse TL, Wilcox JN. Localization of human ATP-binding cassette transporter 1 (ABC1) in normal and atherosclerotic tissues. Arterioscler Thromb Vasc Biol. 2001; 21(3): 378-385.
  • 6Reddy ST, Hama S, Ng C, Grijalva V, Navab M, Fogelman AM. ATP-binding cassette transporter 1 participates in LDL oxidation by artery wall cells. Arterioscler Thromb Vase Biol. 2002; 22(11): 1877-1883.
  • 7Joyce CW, Amar MJ, Lambert G, Vaisman BL, Paigen B, Najib-Fruchart J, Hoyt RF Jr, Neufeld ED, Remaley AT, Fredrickson DS, Brewer HB Jr, Santamarina-Fojo S. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aotric atherosclerosis in C57BL/6 and apoE-knockout mice. Proc Natl Acad Sci U S A. 2002; 99(1): 407-412.
  • 8Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, Shan B, Brown MS, Goldstein JL, Mangelsdorf DJ. Regulation of mouse sterol regulatory element-binding protein-lc gene (SREBP-lc) by oxysterol receptors, LXRa and LXRI3. Genes Dev. 2000; 14 (22) : 2819-2830.
  • 9Zhou J, Febbraio M, Wada T, Zhai Y, Kuruba R, He J, Lee JH, Khadem S, Ren S, Li S, Silverstein RL, Xie W. Hepatic fatty acid transporter Cd86 is a common target of LXR, PXR, and PPART in promoting steatosis.Gastroenterology. 2008; 134(2): 556-567.
  • 10Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM. PPAR7 promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 1998; 93(2) : 241-252.

二级参考文献19

共引文献35

同被引文献278

引证文献23

二级引证文献127

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部